A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
By D. Boumpas, Richard Furie, S. Manzi, G. Illei, D. Wallace, J. Balow, A. Vaishnaw. Arthritis & Rheumatism, 2003
624 citations recorded by the source corpus.
Subfields: Immunology, Rheumatology, Transplantation
View Paper: https://www.semanticscholar.org/paper/db2f26905abd869730d6148158f5b0c5e9b944c6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Follicular B helper T cells in antibody responses and autoimmunity (2005, background): “Patients with SLE who are treated with CD40L-specific antibodies have fewer plasma cells that secrete DNA-specific antibodie”